Circulating proteins reveal prior use of menopausal hormonal therapy and increased risk of breast cancer.
Ontology highlight
ABSTRACT: Accessible risk predictors are crucial for improving the early detection and prognosis of breast cancer. Blood samples are widely available and contain proteins that provide important information about human health and disease, however, little is still known about the contribution of circulating proteins to breast cancer risk prediction. We profiled EDTA plasma samples collected before diagnosis from the Swedish KARMA breast cancer cohort to evaluate circulating proteins as molecular predictors. A data-driven analysis strategy was applied to the molecular phenotypes built on 700 circulating proteins to identify and annotate clusters of women. The unsupervised analysis of 183 future breast cancer cases and 366 age-matched controls revealed five stable clusters with distinct proteomic plasma
SUBMITTER: Thomas CE
PROVIDER: S-EPMC8760550 | biostudies-literature | 2022 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA